Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel Andresen
Institution:
AbbVie (United States)
Observed institution:
AbbVie (United States)
OpenAlex ID:
A5080965320
S38 On-Body Injector Administration of Risankizumab for Treatment of Moderate-to-Severe Crohn’s Disease: Data From the Fortify Open-Label Longitudinal Real-Life Handling Substudy
2022
·
Edward Loftus
, Jenny Griffith
, et al.
·
The American Journal of Gastroenterology
·
2
Show more works
View as search
Works count:
1
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
